PUBLISHER: Market Research Future | PRODUCT CODE: 1677736
PUBLISHER: Market Research Future | PRODUCT CODE: 1677736
Global Migraine Market Research Report Information by Type, By Treatment Type, By Drug Class, And by Region Market Forecast Till 2032
Global Migraine Market Research Report Information by Type (Episodic and Chronic), By Treatment Type (Preventive, Abortive), By Drug Class (Triptans, Ergots, and Others), And by Region (North America, Europe, Asia-Pacific, And Rest of The World) Market Forecast Till 2032
Overview of the Market
In 2023, the migraine market was estimated to be worth USD 5.68 billion. The global migraine market is expected to expand at a compound annual growth rate (CAGR) of 3.83% from 2024 to 2032, from USD 6.00 billion in 2024 to USD 8.42 billion.
The two main factors propelling market expansion are the rise in migraine issues worldwide and the growing public knowledge of new medication classes.
Growing public awareness of new drug classes and a rise in migraine problems globally are two factors influencing the target market's growth. It is also anticipated that the introduction of calcitonin gene-related peptide (CGRP) will facilitate the growth of this enterprise. Migraine is a recurrent, severe headache that is accompanied by photophobia, phonophobia, and nausea. Genes play a role in the development of illness. Out-of-balance emotions, including dejection, tension, anxiety, shock, and excitement, can cause migraine headaches. Each migraine attack varies in length and intensity and often affects one side of the head. Factors include an increase in migraine frequency with substantial unmet needs, rising R&D expenditures resulting in a sizable drug pipeline, and an increase in our understanding of migraine and available treatments.
Perspectives on Market Segments
The migraine market is divided into two divisions based on type: episodic and chronic.
The migraine market is divided into two segments based on the kind of treatment: preventive and abortive.
Surgery has divided the market data into three categories: triptans, ergots, and others.
Regional Perspectives on Migraines
The analysis offers market insights by region, including Asia-Pacific, Europe, North America, and the rest of the world. Throughout the study period, a notable compound annual growth rate (CAGR) is anticipated in the Asia Pacific migraine market. As healthcare expenses rise and infrastructure in emerging countries like China and India improves, the Asia Pacific acute migraine treatment market is predicted to grow in size. The easy availability of reasonably priced migraine treatment choices backed by growing regulatory body initiatives is another significant aspect that is probably propelling the regional market. by the Brand Equity Foundation of India.
The second largest market share is held by the migraine industry in Europe. Two reasons driving the target market's growth are the rise in migraine issues worldwide and the growing public knowledge of new medicine classes. Furthermore, the launch of calcitonin gene-related peptide (CGRP) is expected to support the growth of this sector.
From 2024 to 2032, the North American migraine market is anticipated to expand at the quickest compound annual growth rate. increasing financial contributions from powerful U.S.-based parties. The local market is expected to gain from the substantial research and development activities conducted in the US, Canada, and other nations to identify novel treatment choices. According to the American Family Physician, there are approximately 441.5 million adults in the United States, of whom 6-9% are men and 18-26% are women. In 2009, the United States suffered a migraine.
Key Players
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
- 2.1 DEFINITION
- 2.2 SCOPE OF THE STUDY
- 2.3 RESEARCH OBJECTIVE
- 2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
- 3.1 OVERVIEW
- 3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
4 MARKET DYNAMICS
5 GLOBAL MIGRAINE MARKET, BY MIGRAINE TYPE
6 GLOBAL MIGRAINE MARKET, BY TREATMENT
7 GLOBAL MIGRAINE MARKET, BY DISTRIBUTION CHANNEL
8 GLOBAL MIGRAINE MARKET, BY REGION
9 COMPETITIVE LANDSCAPE
10 COMPANY PROFILES
LIST OF TABLES
- TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
- TABLE 2 GLOBAL MIGRAINE MARKET, BY MIGRAINE TYPE, 2019-2032 (USD MILLION)
- TABLE 3 GLOBAL MIGRAINE MARKET, FOR MIGRAINE WITH AURA, BY REGION, 2019-2032 (USD MILLION)
- TABLE 4 GLOBAL MIGRAINE MARKET, FOR MIGRAINE WITHOUT AURA, BY REGION, 2019-2032 (USD MILLION)
- TABLE 5 GLOBAL MIGRAINE MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
- TABLE 6 GLOBAL MIGRAINE MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
- TABLE 7 GLOBAL MIGRAINE MARKET, FOR MEDICATION, BY REGION, 2019-2032 (USD MILLION)
- TABLE 8 GLOBAL MIGRAINE MARKET, FOR MEDICATION, BY TYPE, 2019-2032 (USD MILLION)
- TABLE 9 GLOBAL MIGRAINE MARKET, FOR CGRP INHIBITORS, BY REGION, 2019-2032 (USD MILLION)
- TABLE 10 GLOBAL MIGRAINE MARKET, FOR CGRP INHIBITORS, BY TYPE, 2019-2032 (USD MILLION)
- TABLE 11 GLOBAL MIGRAINE MARKET, FOR RIMEGEPANT, BY REGION, 2019-2032 (USD MILLION)
- TABLE 12 GLOBAL MIGRAINE MARKET, FOR UBROGEPANT, BY REGION, 2019-2032 (USD MILLION)
LIST OF FIGURES
